CIBC World Market’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
CIBC World Market's DFTX Position: Q3 2026 in Review
CIBC World Market reduced its Definium Therapeutics (DFTX) stake by 15% in Q3 2026, selling an estimated $62.5K and leaving 8,343 shares worth $318K. The position accounts for ﹤0.01% of the portfolio, ranked #1394.
CIBC World Market first reported a position in DFTX in Q3 2021 and has held it in 7 quarters since. The position peaked at $462K in Q2 2026. 349 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.
- CIBC World Market held 8,343 shares of Definium Therapeutics worth $318K as of Q3 2026.
- CIBC World Market sold 1,484 Definium Therapeutics shares in Q3 2026, an estimated $62.5K.
- Definium Therapeutics made up ﹤0.01% of CIBC World Market's portfolio in Q3 2026, its #1394 holding.
- CIBC World Market first reported a position in Definium Therapeutics in Q3 2021 and has held it in 7 quarters since.
- CIBC World Market's Definium Therapeutics position peaked at $462K in Q2 2026.
- 349 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.
Based on CIBC World Market's 13F filing for Q3 2026, filed 10 Nov 2026.